Morgan Stanley’s Charles & Colvard Ltd CTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-300
Closed -$288 8393
2025
Q1
$288 Sell
300
-50
-14% -$66 ﹤0.01% 7433
2024
Q4
$466 Hold
350
﹤0.01% 7349
2024
Q3
$606 Hold
350
﹤0.01% 7279
2024
Q2
$599 Hold
350
﹤0.01% 7214
2024
Q1
$1.19K Sell
350
-429
-55% -$1.64K ﹤0.01% 7149
2023
Q4
$3.19K Buy
779
+390
+100% +$1.62K ﹤0.01% 7072
2023
Q3
$2.23K Hold
389
﹤0.01% 7105
2023
Q2
$3.72K Hold
389
﹤0.01% 7045
2023
Q1
$3.62K Buy
389
+39
+11% +$354 ﹤0.01% 7128
2022
Q4
$2.88K Sell
350
-6
-2% -$56 ﹤0.01% 7284
2022
Q3
$3K Buy
356
+4
+1% +$49 ﹤0.01% 7413
2022
Q2
$4K Sell
352
-85
-19% -$1.19K ﹤0.01% 7473
2022
Q1
$6K Buy
437
+64
+17% +$1.31K ﹤0.01% 7552
2021
Q4
$11K Buy
373
+278
+293% +$8.33K ﹤0.01% 7452
2021
Q3
$3K Sell
95
-104
-52% -$2.88K ﹤0.01% 7619
2021
Q2
$6K Sell
199
-586
-75% -$16.9K ﹤0.01% 7358
2021
Q1
$24K Buy
+785
New +$17.1K ﹤0.01% 6667
2020
Q2
Sell
-2,252
Closed -$15K 6769
2020
Q1
$15K Buy
2,252
+1,209
+116% +$13.1K ﹤0.01% 5915
2019
Q4
$15K Hold
1,043
﹤0.01% 6177
2019
Q3
$17K Hold
1,043
﹤0.01% 6064
2019
Q2
$16K Hold
1,043
﹤0.01% 6006
2019
Q1
$12K Buy
+1,043
New +$10.3K ﹤0.01% 6143
2017
Q4
Sell
-4
Closed 6685
2017
Q3
$0 Buy
+4
New +$35 ﹤0.01% 6641
2017
Q2
Sell
-7
Closed 6674
2017
Q1
$0 Hold
7
﹤0.01% 6627
2016
Q4
$0 Hold
7
﹤0.01% 6581
2016
Q3
$0 Hold
7
﹤0.01% 6580
2016
Q2
$0 Sell
7
-3
-30% -$33 ﹤0.01% 6693
2016
Q1
$0 Sell
10
-30
-75% -$307 ﹤0.01% 6755
2015
Q4
$0 Sell
40
-19
-32% -$236 ﹤0.01% 6833
2015
Q3
$0 Sell
59
-4
-6% -$55 ﹤0.01% 6755
2015
Q2
$0 Hold
63
﹤0.01% 6782
2015
Q1
$0 Hold
63
﹤0.01% 6683
2014
Q4
$1K Sell
63
-6,429
-99% -$131K ﹤0.01% 6499
2014
Q3
$138K Buy
6,492
+83
+1% +$1.74K ﹤0.01% 5326
2014
Q2
$141K Buy
6,409
+2,064
+48% +$47.9K ﹤0.01% 5328
2014
Q1
$124K Buy
4,345
+146
+3% +$6.08K ﹤0.01% 5352
2013
Q4
$212K Buy
4,199
+1,762
+72% +$98.9K ﹤0.01% 4997
2013
Q3
$171K Buy
+2,437
New +$153K ﹤0.01% 4949

Other funds holding CTHR

Morgan Stanley's CTHR Position: Q2 2025 in Review

Morgan Stanley sold out of Charles & Colvard Ltd (CTHR) in Q2 2025, closing a stake of 300 shares — an estimated $288 sold.

Morgan Stanley first reported a position in CTHR in Q3 2013 and held it in 38 quarters. The position peaked at $212K in Q4 2013. 1 fund tracked by Wall St. Rank holds CTHR as of Q2 2025.

  • Morgan Stanley reported no remaining Charles & Colvard Ltd position as of Q2 2025 after selling out during the quarter.
  • Morgan Stanley sold 300 Charles & Colvard Ltd shares in Q2 2025, an estimated $288.
  • Morgan Stanley first reported a position in Charles & Colvard Ltd in Q3 2013 and held it in 38 quarters.
  • Morgan Stanley's Charles & Colvard Ltd position peaked at $212K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held Charles & Colvard Ltd as of Q2 2025.

Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.